{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:37:19Z","timestamp":1770824239768,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The revised 2015 Canadian Guidelines requires a more specific prenatal alcohol exposure (PAE) threshold for a Fetal Alcohol Spectrum Disorder (FASD) diagnosis. The unintended consequences of adhering to the suggested PAE threshold for an FASD diagnosis and the challenges professionals face in obtaining an accurate PAE history were explored.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using a mixed methods study design, the study was carried out in two parts (Quantitative and Qualitative). PAE history and FASD diagnosis was reviewed retrospectively from 146 patient charts referred for an FASD assessment between 2011 and 2016. The challenges experienced when collecting the PAE history were explored through interviews with 23 professionals. Statistical analysis was performed using SPSS (IBM SPSS Statistics 20.0).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 146 assessments, only 21.9% met the revised 2015 PAE guidelines while 79.4% met the previous 2005 PAE criteria. Of 146 clients, 54.1% met brain criteria for FASD yet of those only 29.1% met the revised PAE criteria whereas 70.9% did not and therefore could lose their FASD diagnosis under a diligent application of PAE level suggested in the 2015 Guidelines. Thematic analysis of the interview data indicated that obtaining a reliable PAE history was challenging and a combination of methods are employed to get credible information.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Confirming PAE history can be difficult, but ensuring reliable and accurate details on quantity, frequency, and timing of exposure is impossible in a clinical setting. Three out of every four individuals in the present study lost their FASD diagnosis following implementation of 2015 Canadian FASD Guidelines. A threshold might also imply that alcohol consumption below threshold is safe. The 2015 Canadian Guidelines need further refinement regarding the PAE criteria.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-019-1759-1","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T10:55:10Z","timestamp":1571828110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prenatal alcohol history \u2013 setting a threshold for diagnosis requires a level of detail and accuracy that does not exist"],"prefix":"10.1186","volume":"19","author":[{"given":"Susan","family":"Petryk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0432-1621","authenticated-orcid":false,"given":"Muhammad A.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Ekeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamata","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"key":"1759_CR1","unstructured":"Public Health Agency of Canada. Fetal Alcohol Spectrum Disorder (FASD). A framework for action. Ottawa: Public Health Agency of Canada. Available: \n                    https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/fasd-fw-etcaf-ca\/pdf\/fasd-fw_e.pdf\n                    \n                  . Accessed 15 Oct 2017."},{"issue":"10","key":"1759_CR2","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jamapediatrics.2017.1919","volume":"171","author":"S Lange","year":"2017","unstructured":"Lange S, Probst C, Gmel G, Rehm J, Burd L, Popova S. Global prevalence of fetal alcohol Spectrum disorder among children and youth: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(10):948\u201356.","journal-title":"JAMA Pediatr"},{"key":"1759_CR3","unstructured":"Systematic review on the prevalence of fetal alcohol spectrum disorders. Institute of Health Economics. Available: \n                    http:\/\/fasd.alberta.ca\/documents\/Systematic_Prevalence_Report_FASD.pdf\n                    \n                  . Accessed Jan 2018."},{"issue":"2","key":"1759_CR4","doi-asserted-by":"publisher","first-page":"e20154256","DOI":"10.1542\/peds.2015-4256","volume":"138","author":"H. Eugene Hoyme","year":"2016","unstructured":"Hoyme HE, Kalberg WO, Elliott AJ, Blankenship J, Buckley D, Marais AS, Manning MA, Robinson LK, Adam MP, Abdul-Rahman O, et al. Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders. Pediatrics. 2016;138(2):e20154256.","journal-title":"Pediatrics"},{"key":"1759_CR5","unstructured":"National Screening Tool Kit for Children and Youth Identified and Potentially Affected by FASD. Canadian Association of Paediatric Health Centres. [Available: \n                    https:\/\/ken.caphc.org\/xwiki\/bin\/view\/FASDScreeningToolkit\/National+Screening+Tool+Kit+for+Children+and+Youth+Identified+and+Potentially+Affected+by+FASD\n                    \n                   (accessed Jan 2018)]."},{"issue":"3","key":"1759_CR6","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1016\/S2214-109X(17)30021-9","volume":"5","author":"S Popova","year":"2017","unstructured":"Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(3):e290\u20139.","journal-title":"Lancet Glob Health"},{"key":"1759_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.alcohol.2017.05.004","volume":"67","author":"LN Bakhireva","year":"2018","unstructured":"Bakhireva LN, Garrison L, Shrestha S, Sharkis J, Miranda R, Rogers K. Challenges of diagnosing fetal alcohol spectrum disorders in foster and adopted children. Alcohol. 2018;67:37\u201343.","journal-title":"Alcohol"},{"key":"1759_CR8","unstructured":"Diagnostic Guide for Fetal Alcohol Spectrum Disorders: the 4-Digit Diagnostic Code. Available: \n                    https:\/\/depts.washington.edu\/fasdpn\/pdfs\/guide04.pdf\n                    \n                  . Accessed Mar 2018."},{"issue":"3","key":"1759_CR9","first-page":"e416","volume":"20","author":"SJ Astley","year":"2013","unstructured":"Astley SJ. Validation of the fetal alcohol spectrum disorder (FASD) 4-Digit Diagnostic Code. J Popul Ther Clin Pharmacol. 2013;20(3):e416\u201367.","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"4","key":"1759_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/alcalc\/35.4.400","volume":"35","author":"SJ Astley","year":"2000","unstructured":"Astley SJ, Clarren SK. Diagnosing the full spectrum of fetal alcohol-exposed individuals: introducing the 4-digit diagnostic code. Alcohol Alcohol. 2000;35(4):400\u201310.","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"1759_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1503\/cmaj.141593","volume":"188","author":"JL Cook","year":"2016","unstructured":"Cook JL, Green CR, Lilley CM, Anderson SM, Baldwin ME, Chudley AE, Conry JL, LeBlanc N, Loock CA, Lutke J, et al. Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan. CMAJ. 2016;188(3):191\u20137.","journal-title":"CMAJ"},{"issue":"4","key":"1759_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/pch\/14.4.231","volume":"14","author":"J Benz","year":"2009","unstructured":"Benz J, Rasmussen C, Andrew G. Diagnosing fetal alcohol spectrum disorder: history, challenges and future directions. Paediatr Child Health. 2009;14(4):231\u20137.","journal-title":"Paediatr Child Health"},{"key":"1759_CR13","unstructured":"Hemingway SJA, Bledsoe JM, Davies JK, Brooks A, Jirikowic T, Olson EM, Thorne JC. Twin study confirms virtually identical prenatal alcohol exposures can lead to markedly different fetal alcohol spectrum disorder outcomesfetal genetics influences fetal vulnerability. Adv Pediatr Res. 2019;5(23):1-19."},{"key":"1759_CR14","unstructured":"Mathew B, Miles MH, Saldana J. Qualitative data analysis: a methods sourcebook, fourth edn. Thousand Oaks: SAGE Publications Inc.; 2019."},{"issue":"4","key":"1759_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00004703-200408000-00002","volume":"25","author":"AP Streissguth","year":"2004","unstructured":"Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr. 2004;25(4):228\u201338.","journal-title":"J Dev Behav Pediatr"},{"issue":"5 Suppl","key":"1759_CR16","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1503\/cmaj.1040302","volume":"172","author":"AE Chudley","year":"2005","unstructured":"Chudley AE, Conry J, Cook JL, Loock C, Rosales T, LeBlanc N. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 2005;172(5 Suppl):S1\u2013s21.","journal-title":"CMAJ"},{"issue":"4","key":"1759_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1530-0277.1988.tb00233.x","volume":"12","author":"CB Ernhart","year":"1988","unstructured":"Ernhart CB, Morrow-Tlucak M, Sokol RJ, Martier S. Underreporting of alcohol use in pregnancy. Alcohol Clin Exp Res. 1988;12(4):506\u201311.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"1759_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0163278710381261","volume":"34","author":"JM Payne","year":"2011","unstructured":"Payne JM, France KE, Henley N, D'Antoine HA, Bartu AE, O'Leary CM, Elliott EJ, Bower C, Geelhoed E. RE-AIM evaluation of the alcohol and pregnancy project: educational resources to inform health professionals about prenatal alcohol exposure and fetal alcohol spectrum disorder. Eval Health Prof. 2011;34(1):57\u201380.","journal-title":"Eval Health Prof"},{"key":"1759_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ijlp.2015.08.019","volume":"42-43","author":"NN Brown","year":"2015","unstructured":"Brown NN, Burd L, Grant T, Edwards W, Adler R, Streissguth A. Prenatal alcohol exposure: an assessment strategy for the legal context. Int J Law Psychiatry. 2015;42-43:144\u20138.","journal-title":"Int J Law Psychiatry"},{"issue":"2","key":"1759_CR20","first-page":"e344","volume":"15","author":"YI Goh","year":"2008","unstructured":"Goh YI, Chudley AE, Clarren SK, Koren G, Orrbine E, Rosales T, Rosenbaum C. Development of Canadian screening tools for fetal alcohol spectrum disorder. Can J Clin Pharmacol. 2008;15(2):e344\u201366.","journal-title":"Can J Clin Pharmacol"},{"key":"1759_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.alcohol.2017.02.174","volume":"62","author":"K Dukes","year":"2017","unstructured":"Dukes K, Tripp T, Petersen J, Robinson F, Odendaal H, Elliott A, Willinger M, Hereld D, Raffo C, Kinney HC, et al. A modified Timeline Followback assessment to capture alcohol exposure in pregnant women: Application in the Safe Passage Study. Alcohol. 2017;62:17\u201327.","journal-title":"Alcohol"},{"key":"1759_CR22","first-page":"13","volume":"2","author":"SJ Astley","year":"2017","unstructured":"Astley SJ, Bledsoe JM, Davies JK, Thorne JC. Comparison of the FASD 4-digit code. FASD diagnostic guidelines. Adv Pediatr Res. 2017;2:13.","journal-title":"Adv Pediatr Res"},{"issue":"1","key":"1759_CR23","first-page":"e81","volume":"21","author":"SJ Astley","year":"2014","unstructured":"Astley SJ. The value of a FASD diagnosis (2013). J Popul Ther Clin Pharmacol. 2014;21(1):e81\u2013e105.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"1759_CR24","unstructured":"Number of births in Saskatchewan, Canada in fiscal years 2001 to 2018. [Online]. \n                    https:\/\/www.statista.com\/statistics\/578587\/number-of-births-in-saskatchewan-canada\/\n                    \n                  . Accessed July 2019."},{"key":"1759_CR25","unstructured":"Flannigan K, Unsworth, K, Harding, K. The Prevalence of Fetal Alcohol Spectrum Disorder. 2018; CanFASD. [Online]. \n                    https:\/\/canfasd.ca\/wp-content\/uploads\/sites\/35\/2018\/08\/Prevalence-1-Issue-Paper-FINAL.pdf\n                    \n                  . Accessed July 2019."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1759-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T23:07:28Z","timestamp":1603321648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1759-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1759"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1759-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]},"assertion":[{"value":"24 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the former Regina Research Ethics Board, Saskatchewan Health Authority, Regina, SK, Canada.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"372"}}